08:55 AM EDT, 10/28/2025 (MT Newswires) -- Novartis ( NVS ) is looking to add more medicines to its direct-to-patient platform that is expected to launch in the US on Nov. 1, Reuters reported Tuesday, citing an interview with Chief Executive Vas Narasimhan.

No concrete plans have been confirmed, Reuters cited Narasimhan as saying.

The CEO added that Novartis ( NVS ) was in talks with the US government "every week" on lowering medicine costs for patients, according to the report.

Novartis ( NVS ) did not immediately reply to a request for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)